Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSCW) Return on Equity (2020 - 2025)

Historic Return on Equity for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to 4.82%.

  • Ensysce Biosciences' Return on Equity fell 30000.0% to 4.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.82%, marking a year-over-year decrease of 30000.0%. This contributed to the annual value of 5.25% for FY2024, which is 99800.0% down from last year.
  • Ensysce Biosciences' Return on Equity amounted to 4.82% in Q3 2025, which was down 30000.0% from 2.07% recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Return on Equity ranged from a high of 11.43% in Q1 2023 and a low of 103.96% during Q2 2022
  • For the 5-year period, Ensysce Biosciences' Return on Equity averaged around 8.99%, with its median value being 1.82% (2024).
  • As far as peak fluctuations go, Ensysce Biosciences' Return on Equity tumbled by -312100bps in 2023, and later soared by 250500bps in 2024.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Return on Equity stood at 4.95% in 2021, then decreased by -6bps to 4.66% in 2022, then plummeted by -670bps to 26.56% in 2023, then soared by 94bps to 1.51% in 2024, then crashed by -219bps to 4.82% in 2025.
  • Its last three reported values are 4.82% in Q3 2025, 2.07% for Q2 2025, and 2.04% during Q1 2025.